John Radcliffe's Hospital of Surgeons in Oxford, UK, is used for the first time in the history of genealogy in a & # 39; treatment of age related macular erosion (AMD).
The team led by a professor of ophthalmology at Oxford University, Robert McLaren emerged in an 80-year-old patients with a virus virus with a virus synthetic gene with the aim of bringing the disease back.
The virus prevents epithelial cell (pigmental retine) (RPE) asthma attacks to & # 39; correction of the genetic defect caused by cells to cause protinine that attacks the cells of the saline as bacteria, rather than protesters that are essential to the immune system. The DNA that contains a & # 39; virus thrown that promotes to & # 39; make the right proteins, and restore the patient's sight.
This is the first time that a cure was used to deal with this blind type. Previously, their methods have been used to treat so many historical diseases, such as choroideremia or leber and amurosis.
Previously, AMD was considered as a disorder needed. However, now the work, if there is a positive result, it can only be done once in life.
It is estimated that there is a 2020 world in the world 196 million people affected for this disease, a figure up to 288 million in 2040.
If you like it, share it with your friends!